Clinical trial

Comorbidities And Reducing inEquitieS

NCT04836221

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-05-05

PhaseNA

Study timeline

Study start (actual)2021-05-05Date precision: day

Registry last updated2023-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancer, Breastcandidate · MONDO: breast cancer

Diabetes Mellitusverified · MONDO: diabetes mellitus

Hypertensionunresolved

Cancer Prostateunresolved

Interventions

SupportBEHAVIORAL

Sponsors & collaborators

Medstar Health Research Institutelead sponsor

Pfizercollaborator

American Cancer Society, Inc.collaborator

Mapped research locations

Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04836221 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.